ASH: Gilead’s Kite Plots 2026 Launch For Anito-Cel For Multiple Myeloma

 
• By Alaric DeArment
  
Gilead's booth at the 2025 American Society of Hematology meeting in Orlando, Fla. (Alaric DeArment)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cell Therapies

More from Advanced Therapies